Monitoring of cardiac function by serum cardiac troponin T levels, ventricular repolarisation indices, and echocardiography after conditioning with fractionated total body irradiation and high-dose cyclophosphamide

European Journal of Haematology

Volumn 69, Issue 1, 2002, Pages 1-6

  Auner, H W ^a   Tinchon, C ^a   Brezinschek, R I ^a   Eibl, M ^a   Sormann, S ^a   Maizen, C ^a   Linkesch, W ^a   Schmon Kampel, R ^a   Quehenberger, F ^a   Tiran, A ^a   Sill, H ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

Cardiotoxicity; Cyclophosphamide; Total body irradiation; Transplantation; Troponin T

Indexed keywords

CYCLOPHOSPHAMIDE; TROPONIN T;

ADULT; ARTICLE; BLOOD DISEASE; CARDIOTOXICITY; CLINICAL ARTICLE; DIAGNOSTIC VALUE; DRUG MEGADOSE; ECHOCARDIOGRAPHY; FEMALE; HEART FUNCTION; HEART REPOLARIZATION; HUMAN; IMMUNOASSAY; MALE; MEASUREMENT; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QT INTERVAL; RISK ASSESSMENT; SAFETY; STEM CELL TRANSPLANTATION; WHOLE BODY RADIATION;

ADULT; AGED; CYCLOPHOSPHAMIDE; ECHOCARDIOGRAPHY; HEART FUNCTION TESTS; HEART VENTRICLES; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MIDDLE AGED; MONITORING, PHYSIOLOGIC; STEM CELL TRANSPLANTATION; TRANSPLANTATION CONDITIONING; TROPONIN T; WHOLE-BODY IRRADIATION;

EID: 18644377696     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0609.2002.01661.x     Document Type: Article

References (30)

1. Storb R, Buckner CD, Dillingham LA, Thomas ED. Cyclophosphamide regimens in rhesus monkeys with and without marrow infusion. Cancer Res 1970;30:2195-2203.
2. Baello EB, Ensberg ME, Ferguson DW, et al. Effect of high-dose cyclphosphamide and total-body irradiation on left ventricular function in adult patients with leukemia undergoing allogeneic bone marrow transplantation. Cancer Treat Rep 1986;70:1187-1193.
3. Braverman AC, Antin JH, Plappert MT, et al. Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens. J Clin Oncol 1991;9:1215-1223.
4. Hertenstein B, Stefenic M, Schmeiser T, et al. Cardiac toxicity of bone marrow transplantation: predictive value of cardiologic evaluation before transplant. J Clin Oncol 1994;12:998-1004.
5. Cardinale D, Sandri MT, Martinoni A, et al. Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy. J Am Coll Cardiol 2000;36:517-522.
6. Fujimaki K, Maruta A, Yoshida M, et al. Severe cardiac toxicity in hematological stem cell transplantation: predictive value of reduced left ventricular ejection fraction. Bone Marrow Transplant 2001;27:307-310.
7. Murdych T, Weisdorf DJ. Serious cardiac complications during bone marrow transplantation at the University of Minnesota. Bone Marrow Transplant 2001;28:283-287.
8. Gottdiener JS, Appelbaum FR, Ferrans VJ, et al. Cardiotoxicity associated with high-dose cyclophosphamide therapy. Arch Intern Med 1981;141:758-763.
9. Goldberg MA, Antin JH, Guinan EC, Rappeport JM. Cyclophosphamide cardiotoxicity, an analysis of dosing as a risk factor. Blood 1986;68:1114-1118.
10. Cazin B, Gorin NC, Laporte JP, et al. Cardiac complications after bone marrow transplantation. A report on a series of 63 consecutive transplantations. Cancer 1986;57:2061-2069.
11. Ayash LJ, Wright JE, Tretyakoy O, et al. Cyclophosphamide pharmacokinetics: correlation with cardiac toxicity and tumor response. J Clin Oncol 1992;10:995-1000.
12. Nakamae H, Tsumura K, Hino M, et al. QT dispersion as a predictor of acute heart failure after high-dose cyclophosphamide. Lancet 2000;355:805-806.
13. Kupari M, Volin L, Suokas A, et al. Cardiac involvement in bone marrow transplantation: electrocardiographic changes, arrhythmias, heart failure and autopsy findings. Bone Marrow Transplant 1990;5:91-98.
14. Klootwijk P, Hamm C. Acute coronary syndromes: diagnosis. Lancet 1999;353:10-15.
15. Lipshultz SE, Rifai N, Sallan SE, et al. Predictive value of cardiac troponin T in pediatric patients at risk for myocardial injury. Circulation 1997;96:2641-2648.
16. Auner HW, Tinchon C, Quehenberger F, et al. Troponins in prediction of cardiotoxic effects. Lancet 2001;357:808.
17. Hughes-Davis L, Sacks D, Rescigno J, et al. Serum cardiac troponin T levels during treatment of early-stage breast cancer. J Clin Oncol 1995;13:2582-2584.
18. 2) cyclophosphamide. Bone Marrow Transplant 2001;28:277-282.
19. European Study Group on Diastolic Heart Failure. How to diagnose diastolic heart failure. Eur Heart J 1998;19:990-1003.
20. Singal PK, Iliskovic N. Doxorubicin-induced cardiomyopathy. N Engl J Med 1998;339:900-905.
21. Grenier MA, Lipshultz SE. Epidemiology of anthracycline cardiotoxicity in children and adults. Semin Oncol 1998;25:72-85.
22. Jaenke RS. An anthracycline antibiotic-induced cardiomyopathy in rabbits. Laboratory Invest 1974;30:292-304.
23. Billingham ME, Mason JW, Bristow MR, et al. Anthracycline cardiomyopathy monitored by morphologic changes. Cancer Treat Rep 1978;62:865-872.
24. Lewis W, Gonzalez B. Anthracyclin effects on actin and actin-containing thin filaments in cultured neonatal rat myocardial cells. Laboratory Invest 1986;54:416-423.
25. Molinari A, Calcabrini A, Crateri P, Arancia G. Interaction of anthracyclinic antibiotics with cytoskeletal components of cultured carcinoma cells (CG5). Exp Mol Pathol 1990;53:11-33.
26. Buja LM, Ferrans VJ, Graw RG. Cardiac pathologic findings in patients treated with bone marrow transplantation. Hum Pathol 1976;7:17-45.
27. Auner HW, Tinchon C, Linkesch W, et al. Correspondence re: O.J. Arola et al. Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis. Cancer Res 2001;61:2335-2336.
28. Spargias KS, Lindsay SJ, Kawar GI, et al. QT dispersion as a predictor of long-term mortality in patients with acute myocardial infarction and clinical evidence of heart failure. Eur Heart J 1999;20:1158-1165.
29. Boivin JF, Hutchinson GB, Lubin JH, Mauch P. Coronary artery disease mortality in patients treated for Hodgkin's disease. Cancer 1992;69:1241-1247.
30. Hancock SL, Donaldson SS, Hoppe RT. Cardiac disease following treatment of Hodgkin's disease in children and adolescents. J Clin Oncol 1993;11:1208-1215.